Monogram Technologies Inc. (NASDAQ:MGRM) ... (SIR) review letter that provided preliminary written comments on particular topics of interest before the SIR meeting scheduled for December 17, 2024.

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT FDA Response to 510(k) Filing On October 6, 2024, Monogram (NASDAQ:MGRM) announced it had received an Additional Information ...

(RTTNews) - Monogram Biosciences Inc.(MGRM), Monday announced that the U.S. Food and Drug Administration or FDA has granted 510(k) clearance for its Monogram mBôs TKA System, a robotic-assisted ...